Aaron Hudson
Overview
Explore the profile of Aaron Hudson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi N, et al.
EClinicalMedicine
. 2025 Feb;
80:103054.
PMID: 39902315
Background: With limited access to mRNA COVID-19 vaccines in lower income countries, and people living with HIV (PLWH) largely excluded from clinical trials, Part A of the multicentre CoVPN 3008...
2.
Williamson B, Wu L, Huang Y, Hudson A, B Gilbert P
PLoS One
. 2024 Sep;
19(9):e0310042.
PMID: 39240995
Combination monoclonal broadly neutralizing antibodies (bnAbs) are currently being developed for preventing HIV-1 acquisition. Recent work has focused on predicting in vitro neutralization potency of both individual bnAbs and combination...
3.
Hudson A, Shojaie A
Stat Med
. 2024 Feb;
43(7):1419-1440.
PMID: 38305667
Qualitative interactions occur when a treatment effect or measure of association varies in sign by sub-population. Of particular interest in many biomedical settings are absence/presence qualitative interactions, which occur when...
4.
Juraska M, Bai H, deCamp A, Magaret C, Li L, Gillespie K, et al.
Proc Natl Acad Sci U S A
. 2024 Jan;
121(4):e2308942121.
PMID: 38241441
In the Antibody Mediated Prevention (AMP) trials (HVTN 704/HPTN 085 and HVTN 703/HPTN 081), prevention efficacy (PE) of the monoclonal broadly neutralizing antibody (bnAb) VRC01 (vs. placebo) against HIV-1 acquisition...
5.
Williamson B, Wu L, Huang Y, Hudson A, B Gilbert P
bioRxiv
. 2024 Jan;
PMID: 38168308
Combination monoclonal broadly neutralizing antibodies (bnAbs) are currently being developed for preventing HIV-1 infection. Recent work has focused on predicting in vitro neutralization potency of both individual bnAbs and combination...
6.
Hogue C, Levine A, Hudson A, Lewis C
Anesthesiology
. 2021 Feb;
134(5):784-791.
PMID: 33529323
No abstract available.
7.
Brady K, Hudson A, Hood R, DeCaria B, Lewis C, Hogue C
Anesthesiology
. 2019 Oct;
132(1):170-179.
PMID: 31644437
No abstract available.
8.
Zeigler-Johnson C, Hudson A, Glanz K, Spangler E, Morales K
BMC Cancer
. 2018 Nov;
18(1):1061.
PMID: 30390642
Background: Obesity has been associated with aggressive prostate cancer and poor outcomes. It is important to understand how prognostic tools for that guide prostate cancer treatment may be impacted by...
9.
Culpepper S, Hudson A
Appl Psychol Meas
. 2018 Jun;
42(2):99-115.
PMID: 29881115
A Bayesian formulation for a popular conjunctive cognitive diagnosis model, the reduced reparameterized unified model (rRUM), is developed. The new Bayesian formulation of the rRUM employs a latent response data...